Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ROTIGOTINE vs ROZANOLIXIZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ROTIGOTINE vs ROZANOLIXIZUMAB: Safety Overview

Metric ROTIGOTINE ROZANOLIXIZUMAB
Total FAERS Reports 7,846 303
Deaths Reported 1,299 9
Death Rate 16.6% 3.0%
Hospitalizations 1,727 114
Average Patient Age 70.2 yrs 61.3 yrs
% Female Patients 51.1% 60.9%
FDA Approval Date Apr 2, 2012 N/A
Manufacturer UCB, Inc. UCB, Inc.
Route TRANSDERMAL SUBCUTANEOUS
Marketing Status Prescription N/A